SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318771-03-000012
Filing Date
2003-11-06
Accepted
2003-11-05 19:26:12
Documents
5
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 GENENTECH, INC. - Q3 2003 FORM 10-Q (SEPTEMBER 30, 2003) dna-10q_0903.htm 10-Q 640098
3 LETTER REGARDING UNAUDITED INTERIM FINANCIAL INFORMATION dna-ex15_1.htm EX-15.1 2027
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( dna-ex31_1.htm EX-31.1 5227
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( dna-ex31_2.htm EX-31.2 5539
6 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT T dna-ex32_1.htm EX-32.1 4047
  Complete submission text file 0000318771-03-000012.txt   659326
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Filer) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-09813 | Film No.: 03980771
SIC: 2834 Pharmaceutical Preparations